
The method lent weight to previous research suggesting that part of the structural matrix comprising the capsid, or internal shell of the virus, was a key area to target. The HIV capsid is composed of a honeycomb-like structure, and a sector of the viral sequence called sector 3 of the gag protein helps form the edges of the honeycomb. If that sector were subjected to mutation, the structure would not interlock and the shell would collapse.
Among “elite controllers” - rare patients whose bodies suppress HIV without drugs - the immune system also most commonly targets sector 3, found study co-author Dr. Bruce Walker, director of the Ragon Institute. Even immune systems that fail to control HIV focus on sector 3, but waste their main assault on easily mutating areas of the virus.
The team’s research only focused on “killer” T-cells, which attack HIV-infected cells. However, many researchers believe a successful vaccine also would have to mobilize antibodies that attack free-floating virus. Study co-author Dr. Arup Chakraborty, a professor of chemistry and chemical engineering at the Massachusetts Institute of Technology, is working with Dennis Burton, an HIV antibody expert at Scripps Research Institute, to apply random-matrix theory to antibody-based vaccines.
The full study, “Coordinate Linkage of HIV Evolution Reveals Regions of Immunological Vulnerability,” was published ahead of the print edition of Proceedings of the National Academy of Sciences (2011;doi:10.1073/pnas.1105315108).
The Friends of AIDS Foundation is dedicated to enhancing the quality of life for HIV positive individuals and empowering people to make healthy choices to prevent the spread of the HIV virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.
TOGETHER WE REMAIN STRONG!